Hymeglusin
Hymeglusin is a selective HMG-CoA synthase 1 inhibitor with antibiotic properties. It downregulates BCL2 expression in leukemia cell lines like HL-60 and KG-1, making it a useful compound for studying oncogenesis and potential therapeutic strategies in hematological cancers.
Product Specifications
CAS Number
29066-42-0
Product Name Alternative
L-659699; Antibiotic 1233A; Antibiotic F244
Field of Research
Infectious Disease & Virology
Purity
>98%
Bioactivity
Mevalonate biosynthesis inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
C (O) [C@@H]1[C@@H] (CCCC[C@H] (C/C (=C/C (=C/C (O) =O) /C) /C) C) OC1=O
Molecular Formula
C18H28O5
Molecular Weight
324.41
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
11-[3R- (Hydroxymethyl) -4-oxo-2R-oxetanyl]-3,5,7R-trimethyl-2E,4E-undecadienoic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
